23 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Drug Development
We are delighted to share some highly viewed papers on cancer drug development that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.
The list of relevant papers can be seen below:
“Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition”
by Kentaro Tokumo, Takeshi Masuda, Taku Nakashima, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka et al.
Cancers 2023, 15(4), 1092; https://doi.org/10.3390/cancers15041092
Available online: https://www.mdpi.com/2072-6694/15/4/1092
“Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas”
by Luogen Peng, Yuchan Li, Sha Yao, Jochen Gaedcke, Victor M. Baart, Cornelis F. M. Sier, Albrecht Neesse, Volker Ellenrieder, Hanibal Bohnenberger, Frieder Fuchs et al.
Cancers 2023, 15(5), 1587; https://doi.org/10.3390/cancers15051587
Available online: https://www.mdpi.com/2072-6694/15/5/1587
“The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer”
by Michele Vigolo, Charlotte Urech, Sebastien Lamy, Giulia Monticone, Jovanny Zabaleta, Fokhrul Hossain, Dorota Wyczechowska, Luis Del Valle, Ruth M. O’Regan, Lucio Miele et al.
Cancers 2023, 15(15), 3957; https://doi.org/10.3390/cancers15153957
Available online: https://www.mdpi.com/2072-6694/15/15/3957
“Inhibition of Macropinocytosis Enhances the Sensitivity of Osteosarcoma Cells to Benzethonium Chloride”
by Haichao Xia, Yanran Huang, Lulu Zhang, Lijuan Luo, Xiaoxuan Wang, Qiuping Lu, Jingtao Xu, Chunmei Yang, Habu Jiwa, Shiqiong Liang et al.
Cancers 2023, 15(3), 961; https://doi.org/10.3390/cancers15030961
Available online: https://www.mdpi.com/2072-6694/15/3/961
“Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms”
by Himali Gujrati, Siyoung Ha and Bi-Dar Wang
Cancers 2023, 15(12), 3140; https://doi.org/10.3390/cancers15123140
Available online: https://www.mdpi.com/2072-6694/15/12/3140
“Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues”
by Annalisa Schirizzi, Giampiero De Leonardis, Vincenza Lorusso, Rossella Donghia, Alessandro Rizzo, Simona Vallarelli, Carmela Ostuni, Laura Troiani, Ivan Roberto Lolli, Gianluigi Giannelli et al.
Cancers 2023, 15(8), 2376; https://doi.org/10.3390/cancers15082376
Available online: https://www.mdpi.com/2072-6694/15/8/2376
Special Issues:
|
Edited by Dr. Rajeev K. Singla and Prof. Dr. Anupam Bishayee
|
“Cancer Cell Metabolism and Drug Targets” Edited by Dr. Daniel S. Sitar and Prof. Dr. Donald Miller |
|
“Molecular Mechanisms of Anti-cancer Drugs Action” Edited by Dr. Barbara Pucelik
|
“The Roles of microRNAs in Cancer Aggressiveness and Drug Resistance, Volume II” Edited by Dr. Bi-Dar Wang and Prof. Dr. Luciane R Cavalli
|
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
